Protagonist Therapeutics
PTGX
#3927
Rank
$2.42 B
Marketcap
$40.65
Share price
5.17%
Change (1 day)
135.79%
Change (1 year)

Earnings for Protagonist Therapeutics (PTGX)

Earnings in 2024 (TTM): $0.17 Billion USD

According to Protagonist Therapeutics 's latest financial reports the company's current earnings are $0.31 Billion USD. In 2023 the company made an earning of -$78.96 Million USD, an increase over its 2022 earnings that were of -$0.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protagonist Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.17 B-318.61%
2023 -$78.96 Million-38.02%
2022 -$0.13 Billion1.47%
2021 -$0.13 Billion93.62%
2020 -$64.85 Million-16.74%
2019 -$77.88 Million96.06%
2018 -$39.73 Million7.48%
2017 -$36.96 Million-0.59%
2016 -$37.18 Million150.22%
2015 -$14.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.13 Billion-172.49%๐Ÿ‡บ๐Ÿ‡ธ USA